Remove 2012 Remove Packaging Remove Protein Production
article thumbnail

Gene editing extends lifespan in mouse model of prion disease

Broad Institute

A long-awaited strategy Vallabh and Minikel have been studying prion disease since 2012, after Vallabhs mother passed away from a form of the disease called fatal familial insomnia and Vallabh found out that she had inherited the disease-causing mutation. They then administered the AAVs to mice infected with the human prion protein.

Disease 144
article thumbnail

Beyond Steel Tanks

Codon

In the case of semaglutide, those cells are Saccharomyces cerevisiae— also known as Baker’s yeast — engineered to secrete a peptide precursor that is later purified, chemically modified, packaged into an injectable or tablet form, and then shipped around the world. Continuing this method may not scale.